**Question:** All of the following clinicopathologic features are seen more often in seminomas as compared to non-seminomatous germ cell tumors of the testis except:

A. High age at presentation
B. Pure seminoma histology
C. Extragonadal involvement
D. Poor tumor markers response

**Core Concept:** Seminomas and non-seminomatous germ cell tumors (NSGCTs) are two main types of germ cell tumors that can arise in the testis. Seminomas are characterized by the presence of pure seminoma histology (option B), better prognosis, and often occur in younger patients (option A). Non-seminomatous germ cell tumors, on the other hand, are more diverse in histological types, have a poorer prognosis, and are commonly associated with elevated tumor markers (option D). Extragonadal involvement (option C) is a feature primarily seen in NSGCTs, not seminomas.

**Why the Correct Answer is Right:** Extragonadal involvement refers to the presence of germ cell tumor outside the testis or epididymis. Since seminomas are a subgroup of germ cell tumors, they can potentially involve extragonadal sites as well. However, this feature is predominantly seen in non-seminomatous germ cell tumors (NSGCTs), making option C (extragonadal involvement) the correct answer.

**Why Each Wrong Option is Incorrect:**

A. High age at presentation is a feature more commonly associated with NSGCTs, not seminomas. Seminomas typically present at a younger age.

B. Pure seminoma histology is a defining feature of seminomas, making option B incorrect for this feature.

D. Poor tumor markers response indicates a poorer prognosis in germ cell tumors, which is more characteristic of NSGCTs, not seminomas. Seminomas generally exhibit better tumor marker response.

**Clinical Pearl:** Testicular germ cell tumors (GCTs) are divided into seminomas and non-seminomatous GCTs (NSGCTs). Seminomas are characterized by a younger age at presentation, pure seminoma histology, and better tumor marker response, while NSGCTs present at an older age, have mixed histology, and have a poorer prognosis. Understanding these features can guide appropriate management and treatment strategies for patients with testicular GCTs.